Diabetes Tech News: Medtronic Launches First-Of-Its-Kind mySentry™ Remote Glucose Monitor
Wednesday, January 4, 2012 at 9:37AM Medtronic announces mySentry and I rejoice. Their new innovation does sound familiar...
mySentry Allows Caregivers to See Real-Time Insulin Pump Information and Glucose Trends from Another Room
MINNEAPOLIS – January 4, 2012 – Today, Medtronic, Inc. (NYSE:MDT) announced U.S. Food and Drug Administration (FDA) approval and U.S. market launch of the first-of-its-kind mySentry™ Remote Glucose Monitor, which allows a parent or caregiver to monitor from another room a patient’s MiniMed Paradigm® REAL-Time Revel™ System. The remote glucose monitor also marks the launch of a new category of Connected Care solutions that will provide people with diabetes and their caregivers convenient options to access their diabetes management information.
Perhaps more then any other chronic dieses, management of day-to-day diabetes lends itself to cutting edge technology. While I'm always grateful for the advancements that have already been made, I'd like to see more and see it faster.
Even if you don't use a Medtronic device (Arden uses a DexCom CGM) this news is fantastic. Wireless technology like this is sorely needed and Medtronic's announcement will serve us all well, spurning other manufacturers to move forward as quickly as possible so not to be left behind. It is also a signal to other companies that the FDA is allowing clearance for technology such as this. That knowledge will make it easier for smaller companies to get into the game. Many device manufacturers are smaller and less profitable then you may imagine and they can't afford to get trapped into a protracted submission process with the government.
I love the FDA saying yes, I love Medtronic trying and I look forward to finding out what is next - please just don't price us all out of when your products come to market.
Medtronic's complete press release is at this link.
ps. It's time to let Insulet give us their smaller pods FDA - I mean really... which ever device lobbyist has you holding this up (my supposition)... they've gotten their monies worth, time to think about the people again.
CGM, FDA, In the News, Medtronic, technology in DexCom Blog, Type I News
Reader Comments (5)
Great news, my daughter kennedy, now 11, was diagnosed over this past summer, we are so far on Omnipod, looking into dex... She was 350 when she got home from school today, and 350 in math class, had to battle with her teacher not to take a test!
Wouldn't I like to have that cgm data at my disposal while I am at work?
I'll take it a step further... Wouldn't I like to have the data within her electronic medical record? Oh, I forgot to mention I am also a pediatrician.
These are simple data interfaces, as you would line up a billing interface, etc...
The issue is the revenue model of such projects...
Good stuff! Makes me optimistic again!
Does Kennedy have a 504? Arden's will specifically denote that her BG must be in a certain range to participate in a test beginning in 3rd grade.
To the CGM stuff... how great is it that tech in the personal medical device world appear to be catching up with cell phones. I think that I partially mean that sarcastically and partially I don't...
I love that you're optimistic again!
Good news! I will be so thrilled when FDA moves forward with the Insulet product. Can't wait, literally!
Even though I don't use Medtronic either, I think this is good as well. It's been too long since something new is actually available to us in the US and I hope this is a sign of more things to come. Soon!
I'm all for safety but the bureaucracy is ridiculous. No different then the rest of our world I guess but still disappointing.